Abstract
Ursodeoxycholic acid (UDCA) has been used to treat people with CFLD for years, and usually started in childhood or adolescence. This study aims to assess the effect of stopping UDCA on Liver Function Tests (LFT’s) and liver stiffness measurement (LSM) using ultrasound shear wave elastography of adult patients with CF-related liver disease (PwCFLD) under the care of the All Wales Adult CF Centre (AWACFC).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date
